Skip to main content

Table 2 Changes in diabetes and lipid parameters and LnRHI

From: A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus

 

Ezetimibe (n  = 17)

p − value

Atorvastatin (n  = 16)

p − value

 

Baseline

 

6 months

 

Baseline

 

6 months

 

Hemoglobin A1c (%)

7.3 ± 1.1

 

7.5 ± 0.8

0.307

6.9 ± 0.6

 

6.7 ± 0.7

0.062

% change (%)

 

3.9 ± 13.3

   

−0.3 ± 2.1

  

Fasting plasma glucose (mg/dL)

135.8 ± 21.5

 

135.8 ± 27.9

0.581

131.4 ± 21.4

 

133.9 ± 25.5

0.651

% change (%)

 

2.6 ± 15.3

   

2.8 ± 7.8

  

Total cholesterol (mg/dL)

237.5 ± 25.8

 

195.7 ± 21.6

<0.001

226.6 ± 29.5

 

174.4 ± 22.2

<0.001

% change (%)

 

−17.1 ± 9.3‡

   

−22.8 ± 6.1‡

  

LDL cholesterol (mg/dL)

148.8 ± 22.1

 

115.5 ± 17.9

<0.001

135.6 ± 19.7

 

88.9 ± 17.5

<0.001

% change (%)

 

−21.9 ± 9.6*

   

−34.5 ± 7.8*

  

HDL cholesterol (mg/dL)

57.0 ± 11.3

 

54.9 ± 12.6

0.31

54.9 ± 19.0

 

58.0 ± 18.5

0.035

% change (%)

 

−3.4 ± 12.1‡

   

6.5 ± 10.5‡

  

Triglyceride (mg/dL)

112.0 (100.0–192.5)

 

94.0 (80.0–171.0)

0.18

134.5 (76.3–229.3)

 

105 (67.0–188.3)

0.12

% change (%)

 

−8.9 ± 28.1

   

−7.0 ± 45.0

  

NEFA (mg/dL)

561.1 ± 236.8

 

429.7 ± 195.9

0.009

538.8 ± 319.5

 

520.2 ± 227.3

0.746

% change (%)

 

−19.9 ± 27.4‡

   

11.3 ± 44.1‡

  

Lathosterol (μg/mL)

3.30 ± 1.45

 

4.60 ± 1.96

0.004

3.44 ± 1.52

 

1.57 ± 0.61

<0.001

% change (%)

 

51.2 ± 52.2*

   

−42.0 ± 49.7*

  

Campesterol (μg/mL)

6.14 ± 2.74

 

2.69 ± 0.72

<0.001

6.56 ± 1.53

 

6.21 ± 1.86

0.217

% change (%)

 

−51.0 ± 17.7*

   

−6.5 ± 23.3*

  

Lathosterol/campesterol

0.457 (0.337–1.006)

 

1.428 (1.189–2.303)

<0.001

0.593 (0.282–0.678)

 

0.276 (0.205–0.311)

0.002

% change (%)

 

239.3 ± 38.5*

   

−39.2 ± 38.5*

  

LnRHI

0.471 ± 0.157

 

0.678 ± 0.187

0.007

0.552 ± 0.084

 

0.558 ± 0.202

0.645

% change (%)

 

63.3 ± 89.2‡

   

7.4 ± 41.2‡

  
  1. LDL: low-density lipoprotein, HDL: high-density lipoprotein, NEFA: non-esterified fatty acid, LnRHI: natural logarithmic transformed value of reactive hyperemia peripheral tonometry index. * p < 0.001, ‡ p < 0.05; ezetimibe vs. atorvastatin.